Reliance GeneMedix PLC AGM Confirmation of Delisting (4616N)
28 September 2012 - 1:30PM
UK Regulatory
TIDMGMX
RNS Number : 4616N
Reliance GeneMedix PLC
28 September 2012
FOR IMMEDIATE RELEASE 28 September 2012
Reliance GeneMedix plc
(AIM: GMX)
Result of AGM
The board of Reliance GeneMedix plc ("Reliance GeneMedix" or the
"Company") announces that at the Annual General Meeting of the
Company's shareholders held today all resolutions were duly passed
including those to cancel the admission to trading on AIM of the
Ordinary Shares and to re-register the Company as a private limited
company. Consequently, it is expected that the last day of dealings
in the Ordinary Shares on AIM will be 5 October 2012 and it is
expected that the cancellation of admission to trading on AIM of
the Ordinary Shares will take effect from 7.00a.m. (British Summer
Time) on 8 October 2012. The earliest date that the Company will be
re-registered as a private limited company is expected to be 26
October 2012.
If Shareholders wish to buy or sell Ordinary Shares on AIM they
must do so prior to the De-Listing becoming effective.
If any of the above dates change, the revised dates will be
notified to Shareholders by a further announcement through a
Regulatory Information Service. Unless otherwise defined, terms
used in this announcement have the meaning given to them in the
circular sent to Shareholders on 5 September 2012.
In accordance with AIM Rule 26, a copy of this announcement is
available on the Company's website at www.genemedix.com.
ENQUIRIES:
Reliance GeneMedix plc Tel: +353 57 932 3572
Vinay Ranade, Chief Executive Officer
Deloitte Corporate Finance Tel: 020 7936 3000
Jonathan Hinton, John Ball
Lothbury Financial Services Tel: 020 7868 2567
Michael Padley
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCGMGZLMRNGZZM
Reliance Genemedix (LSE:GMX)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Reliance Genemedix (LSE:GMX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
Echtzeit-Nachrichten über Reliance Gen. (Londoner Börse): 0 Nachrichtenartikel
Weitere Reliance Genemedix News-Artikel